Details of the Drug

General Information of Drug (ID: DMX6AJ8)

Drug Name

ZM-H1505R

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis B	1E51	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hepatitis B virus Capsid protein (HBV C)	TTM42UJ	CAPSD_HBVD3	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04220801) A Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Doses in Healthy Participants. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Shanghai Zhimeng Biopharma.